Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
The problem caused by AT heterozygotes in the increase in cancers is
controversed.
The radiation protection limitation recommandations are primarily based on
the estimation of excess risk of whole populations. Currently the ICRP
(Publication 79, 1998, page 138) does not recommend the take into
consideration of these particular populations: "insufficient to form the
basis of special precautions".
With regard to the AT heterozygotes for norm recommendations, ICRP
estimates that the controversy brought eg by Fitzgerald et al.(1),
currently do not allow the taking into account of the heterozygous AT .
This position does not hold any account of the precautionary principle
(2).
However this precautionary principle should obviously apply in this case,
taking into account many studies (3) which show a risk clearly increased
in this population.
If one were to hold account of the results obtained in particular by Athma
et al.(4), it is probable that the limits of doses recommended for the
workers (ICRP, Publication 60, 1990) would be still lowered.
In the field of protection against radiation, one can notice that the
taking into account of the occupational hazard is rarely based on early
indicative results, but mainly on late obviousnesses.
(1) FitzGerald MG, Bean JM, Hedge SR, Unsal H, MacDonald DJ, Harkin
DP, Finkelstein DM, Isselbacher KJ, Haber DA. Heterozygous ATM mutations
do not contribute to early onset of breast cancer. Nat Genet. 1997; 15:
307-310.
(2) Communication from the Commission on the precautionary principle. COM
(2000) 1 (01). 2-2-2000.
(3) Janin N, Andrieu N, Ossian K, Lauge A, Croquette MF, Griscelli C,
Debre M, Bressac de Paillerets B, Aurias A, Stoppa-Lyonnet D. Breast
cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study
in French AT families. Br J Cancer. 1999; 80: 1042-1045.
(4)Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-
telangiectasia heterozygotes are predisposed to breast cancer. Cancer
Genet Cytogenet. 1996; 92: 130-134.
Competing interests:
No competing interests
01 September 2000
Christophe De Brouwer
Directeur du laboratoire de Santé au Travail et de Toxicologie du Milieu.
School of Public Health. Université Libre de Bruxelles
Radiation protection norms and A-T
The problem caused by AT heterozygotes in the increase in cancers is
controversed.
The radiation protection limitation recommandations are primarily based on
the estimation of excess risk of whole populations. Currently the ICRP
(Publication 79, 1998, page 138) does not recommend the take into
consideration of these particular populations: "insufficient to form the
basis of special precautions".
With regard to the AT heterozygotes for norm recommendations, ICRP
estimates that the controversy brought eg by Fitzgerald et al.(1),
currently do not allow the taking into account of the heterozygous AT .
This position does not hold any account of the precautionary principle
(2).
However this precautionary principle should obviously apply in this case,
taking into account many studies (3) which show a risk clearly increased
in this population.
If one were to hold account of the results obtained in particular by Athma
et al.(4), it is probable that the limits of doses recommended for the
workers (ICRP, Publication 60, 1990) would be still lowered.
In the field of protection against radiation, one can notice that the
taking into account of the occupational hazard is rarely based on early
indicative results, but mainly on late obviousnesses.
(1) FitzGerald MG, Bean JM, Hedge SR, Unsal H, MacDonald DJ, Harkin
DP, Finkelstein DM, Isselbacher KJ, Haber DA. Heterozygous ATM mutations
do not contribute to early onset of breast cancer. Nat Genet. 1997; 15:
307-310.
(2) Communication from the Commission on the precautionary principle. COM
(2000) 1 (01). 2-2-2000.
(3) Janin N, Andrieu N, Ossian K, Lauge A, Croquette MF, Griscelli C,
Debre M, Bressac de Paillerets B, Aurias A, Stoppa-Lyonnet D. Breast
cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study
in French AT families. Br J Cancer. 1999; 80: 1042-1045.
(4)Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-
telangiectasia heterozygotes are predisposed to breast cancer. Cancer
Genet Cytogenet. 1996; 92: 130-134.
Competing interests: No competing interests